MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Progress in Molecular Biology and Translational Science

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/bs.pmbts.2016.12.009PMID 28253983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNAs underlying memory deficits in neurodegenerative disorders

  2017cited by this paper
• A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

  2017cited by this paper
• MicroRNA-15b regulates mitochondrial ROS production and the senescence-associated secretory phenotype through sirtuin 4/SIRT4

  2016cited by this paper
• Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders

  2016cited by this paper
• MicroRNA-135b has a neuroprotective role via targeting of β-site APP-cleaving enzyme 1.

  2016cited by this paper
• Differential DNA Methylation of MicroRNA Genes in Temporal Cortex from Alzheimer's Disease Individuals

  2016cited by this paper
• Fat-specific Dicer deficiency accelerates aging and mitigates several effects of dietary restriction in mice

  2016cited by this paper
• Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?

  2016cited by this paper
• Genome-wide identification of microRNA-related variants associated with risk of Alzheimer’s disease

  2016cited by this paper
• The miR-15/107 Family of microRNA Genes Regulates CDK5R1/p35 with Implications for Alzheimer’s Disease Pathogenesis

  2016cited by this paper
• Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.

  2016cited by this paper
• Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis.

  2016cited by this paper
• Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity.

  2016cited by this paper
• Primate-specific miR-603 is implicated in the risk and pathogenesis of Alzheimer's disease

  2016cited by this paper
• Recombinant pre-miR-29b for Alzheimer´s disease therapeutics

  2016cited by this paper
• microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain

  2015cited by this paper
• Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment

  2015cited by this paper
• MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo.

  2015cited by this paper
• MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease

  2015cited by this paper
• miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway

  2015cited by this paper
• Mutation in the 3’untranslated region of APP as a genetic determinant of cerebral amyloid angiopathy

  2015cited by this paper
• Modulation of a Specific Pattern of microRNAs, Including miR-29a, miR-30a and miR-34a, in Cultured Human Skin Fibroblasts, in Response to the Application of a Biofunctional Ingredient that Protects against Cellular Senescence in Vitro

  2015cited by this paper
• Mir-23a induces telomere dysfunction and cellular senescence by inhibiting TRF2 expression

  2015cited by this paper
• miR-512-5p Suppresses Tumor Growth by Targeting hTERT in Telomerase Positive Head and Neck Squamous Cell Carcinoma In Vitro and In Vivo

  2015cited by this paper
• MiR-16 regulates cell death in Alzheimer's disease by targeting amyloid precursor protein.

  2015cited by this paper
• MicroRNA-26a supports mammalian axon regeneration in vivo by suppressing GSK3β expression

  2015cited by this paper
• Benzo-α-pyrene induced oxidative stress in Caenorhabditis elegans and the potential involvements of microRNA.

  2015cited by this paper
• MicroRNAs in Salivary Exosome as Potential Biomarkers of Aging

  2015cited by this paper
• Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau.

  2015cited by this paper
• miR-155 is involved in Alzheimer’s disease by regulating T lymphocyte function

  2015cited by this paper
• A Complex Genome-MicroRNA Interplay in Human Mitochondria

  2015cited by this paper
• miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

  2014cited by this paper
• MiR-206 decreases brain-derived neurotrophic factor levels in a transgenic mouse model of Alzheimer’s disease

  2014cited by this paper
• MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease.

  2014cited by this paper
• Age-dependent neuron loss is associated with impaired adult neurogenesis in forebrain neuron-specific Dicer conditional knockout mice.

  2014cited by this paper
• The effects of age upon the expression of three miRNAs in muscle stem cells isolated from two different porcine skeletal muscles.

  2014cited by this paper
• Upregulated sirtuin 1 by miRNA-34a is required for smooth muscle cell differentiation from pluripotent stem cells

  2014cited by this paper
• Screening of microRNAs associated with Alzheimer's disease using oxidative stress cell model and different strains of senescence accelerated mice.

  2014cited by this paper
• miR-19b promotes tumor growth and metastasis via targeting TP53

  2014cited by this paper
• MicroRNA-22 Regulates Smooth Muscle Cell Differentiation From Stem Cells by Targeting Methyl CpG–Binding Protein 2

  2014cited by this paper
• miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export.

  2014cited by this paper
• Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128

  2014cited by this paper
• MicroRNA‐125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease

  2014cited by this paper
• MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons

  2014cited by this paper
• Circulating miR-125b as a biomarker of Alzheimer's disease.

  2014cited by this paper
• Profile of microRNAs associated with aging in rat liver.

  2014cited by this paper
• Involvement of MicroRNAs in the Regulation of Muscle Wasting during Catabolic Conditions

  2014cited by this paper
• miR-155 drives telomere fragility in human breast cancer by targeting TRF1.

  2014cited by this paper
• Synaptic and Cognitive Improvements by Inhibition of 2-AG Metabolism Are through Upregulation of MicroRNA-188-3p in a Mouse Model of Alzheimer's Disease

  2014cited by this paper
• Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders

  2014cited by this paper
• Circulating miRNAs as Potential Biomarkers in Alzheimer's Disease

  2014cited by this paper
• Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease

  2013cited by this paper
• MicroRNA-339-5p Down-regulates Protein Expression of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 (BACE1) in Human Primary Brain Cultures and Is Reduced in Brain Tissue Specimens of Alzheimer Disease Subjects*

  2013cited by this paper
• MiR-26b, Upregulated in Alzheimer's Disease, Activates Cell Cycle Entry, Tau-Phosphorylation, and Apoptosis in Postmitotic Neurons

  2013cited by this paper
• Identification of microRNAs dysregulated in cellular senescence driven by endogenous genotoxic stress

  2013cited by this paper
• miR-761 regulates the mitochondrial network by targeting mitochondrial fission factor.

  2013cited by this paper
• Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controls

  2013cited by this paper
• DGCR8‐mediated disruption of miRNA biogenesis induces cellular senescence in primary fibroblasts

  2013cited by this paper
• Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR‐21 in estrogen deficiency–induced osteoporosis

  2013cited by this paper
• Circulating miRNAs as Potential Marker for Pulmonary Hypertension

  2013cited by this paper
• Expression of the phagocytosis-essential protein TREM2 is down-regulated by an aluminum-induced miRNA-34a in a murine microglial cell line.

  2013cited by this paper
• KSRP Modulation of GAP-43 mRNA Stability Restricts Axonal Outgrowth in Embryonic Hippocampal Neurons

  2013cited by this paper
• The emerging role of microRNA in stroke.

  2013cited by this paper
• Cellular senescence mediated by p16INK4A-coupled miRNA pathways

  2013cited by this paper
• Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes

  2013cited by this paper
• NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection?

  2013cited by this paper
• Alternative polyadenylation and miR‐34 family members regulate tau expression

  2013cited by this paper
• MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment.

  2013cited by this paper
• De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease.

  2013cited by this paper
• Age-related changes in microRNA levels in serum

  2013cited by this paper
• A miR-1207-5p Binding Site Polymorphism Abolishes Regulation of HBEGF and Is Associated with Disease Severity in CFHR5 Nephropathy

  2012cited by this paper
• MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation.

  2012cited by this paper
• Up-Regulation of microRNA-126 May Contribute to Pathogenesis of Ulcerative Colitis via Regulating NF-kappaB Inhibitor IκBα

  2012cited by this paper
• Plasma-Based Circulating MicroRNA Biomarkers for Parkinson's Disease

  2012cited by this paper
• Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10

  2012cited by this paper
• microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF).

  2012cited by this paper
• VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma.

  2012cited by this paper
• MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice.

  2012cited by this paper
• Regulation of Complement Factor H (CFH) by Multiple miRNAs in Alzheimer’s Disease (AD) Brain

  2012cited by this paper
• miR-214 targets ATF4 to inhibit bone formation

  2012cited by this paper
• Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes

  2012cited by this paper
• Decoding the non-coding RNAs in Alzheimer’s disease

  2012cited by this paper
• MicroRNA dysregulation in schizophrenia.

  2012cited by this paper
• Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.

  2012cited by this paper
• Circulating miRNA profiles in patients with metabolic syndrome.

  2012cited by this paper
• Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging.

  2012cited by this paper
• microRNA expression profiles in human colorectal cancers with brain metastases.

  2012cited by this paper
• miR‐206 regulates brain‐derived neurotrophic factor in Alzheimer disease model

  2012cited by this paper
• MicroRNAs in Parkinson's disease.

  2012cited by this paper
• Cell-to-cell miRNA transfer: from body homeostasis to therapy.

  2012cited by this paper
• An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration

  2012cited by this paper
• The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease.

  2012cited by this paper
• A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts

  2011cited by this paper
• Short Telomeres Compromise β-Cell Signaling and Survival

  2011cited by this paper
• MicroRNA-9 Reveals Regional Diversity of Neural Progenitors along the Anterior-Posterior Axis

  2011cited by this paper
• MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis

  2011cited by this paper
• MicroRNA-9 promotes differentiation of mouse bone mesenchymal stem cells into neurons by Notch signaling

  2011cited by this paper
• miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes.

  2011cited by this paper
• Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer

  2011cited by this paper
• miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition

  2011cited by this paper

• Serotonin-mediated regulation of mitophagy in Alzheimer's disease: mechanistic insights and therapeutic potential.

  2025cites this paper
• Hyperoside Promotes Mitochondrial Autophagy Through the miR-361-5p/PI3K/Akt/mTOR Signaling Pathway, Thereby Improving UVB-Induced Photoaging

  2025cites this paper
• Mitochondrial transplantation in lung diseases: From mechanisms to application prospects

  2025cites this paper
• Ketone monoester alleviates cognitive impairment in a transgenic mouse model of Alzheimer's disease through innate immunological IFITM3 pathway.

  2025cites this paper
• MiRNA‐501‐3p and MiRNA‐502‐3p: A promising biomarker panel for Alzheimer's disease

  2025cites this paper
• MicroRNA-502-3p Modulates the GABA A Subunits, Synaptic Proteins, and Mitochondrial Morphology in Hippocampal Neurons

  2025cites this paper
• Research progress of cell senescence in Alzheimer's disease: mechanisms and therapy.

  2025cites this paper
• In silico detection of dysregulated genes and molecular pathways in Alzheimer’s disease as basis for food restoring approach

  2025cites this paper
• A Novel Molecular Regulatory Network in Bone Marrow Mesenchymal Stem Cells for Age‐Related Osteoporosis

  2025cites this paper
• Mitophagy in Alzheimer's disease and other metabolic disorders: a focus on mitochondrial-targeted therapeutics.

  2025cites this paper
• Current aspects of targeting cellular senescence for the therapy of neurodegenerative diseases

  2025cites this paper
• Multi-omics integration reveals key miRNAs, immune inflammation, and signaling pathways in Alzheimer's disease: Implications for targeted therapy.

  2025cites this paper
• Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.

  2024cites this paper
• A Comprehensive Review of Membrane Transporters and MicroRNA Regulation in Alzheimer’s Disease

  2024cites this paper
• Unveiling the Role of Novel miRNA PC-5P-12969 in Alleviating Alzheimer’s Disease

  2024cites this paper
• Perinatal Tissue-Derived Stem Cells: An Emerging Therapeutic Strategy for Challenging Neurodegenerative Diseases

  2024cites this paper
• Aberrant Expression of Messenger and Small Noncoding RNAomes in aged Skin of Rats.

  2024cites this paper
• Epigenetic Biomarkers in Alzheimer's Disease: Diagnostic and Prognostic Relevance.

  2024cites this paper
• c-Jun N-terminal kinase signaling in aging

  2024cites this paper
• Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer's disease.

  2024cites this paper
• The molecular mechanism of γ-aminobutyric acid against AD: the role of CEBPα/circAPLP2/miR-671-5p in regulating CNTN1/2 expression.

  2023cites this paper
• Future Trends in Pharmaceuticals: Investigation of the Role of AI in Drug Discovery, 3D Printing of Medications, and Nanomedicine

  2023cites this paper
• Factors affecting the GABAergic synapse function in Alzheimer's Disease: Focus on microRNAs.

  2023cites this paper
• Aging, Cellular Senescence, and Glaucoma

  2023cites this paper
• MicroRNA networks linked with BRCA1/2, PTEN, and common genes for Alzheimer's disease and breast cancer share highly enriched pathways that may unravel targets for the AD/BC comorbidity treatment

  2023cites this paper
• Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer’s Disease

  2023cites this paper
• Age‑related brainstem degeneration through microRNA modulation in mice

  2023cites this paper
• MiR-24-3p/Dio3 axis is essential for BDE47 to induce local thyroid hormone disorder and neurotoxicity.

  2023cites this paper
• Presequence protease reverses mitochondria‐specific amyloid‐β‐induced mitophagy to protect mitochondria

  2023cites this paper
• A comprehensive overview of cellular senescence from 1990 to 2021: A machine learning-based bibliometric analysis

  2023cites this paper
• Potential of hsa-miR200a-3p and hsa-miR502-3p as blood-based biomarker for Alzheimer’s disease

  2022cites this paper
• Genetik und Epigenetik des Alterns

  2022cites this paper
• Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis

  2022cites this paper
• Missorting of plasma miRNAs in aging and Alzheimer's disease

  2022cites this paper
• SDGCCA: Supervised Deep Generalized Canonical Correlation Analysis for Multi-Omics Integration

  2022cites this paper
• Promise of Irisin to Attenuate Cognitive Dysfunction in Aging and Alzheimer's Disease.

  2022cites this paper
• MiR-146b-5p/TRAF6 axis is essential for Ginkgo biloba L. extract GBE to attenuate LPS-induced neuroinflammation

  2022cites this paper
• The role of microRNAs in neurodegenerative diseases: a review

  2022cites this paper
• Identification of hsa-miR-365b-5p's role in Alzheimer's disease: a combined analysis of miRNA and mRNA microarrays.

  2022cites this paper
• Implications of Microorganisms in Alzheimer’s Disease

  2022cites this paper
• Forensic age estimation from human blood using age-related microRNAs and circular RNAs markers

  2022cites this paper
• Defective Autophagy and Mitophagy in Aging and Alzheimer’s Disease

  2021cites this paper
• Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress

  2021cites this paper
• New insights of epigenetics in vascular and cellular senescence

  2021cites this paper
• Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet–Mediated Amyloid Aggregation in Alzheimer’s Disease

  2021cites this paper
• The Moringin/α-CD Pretreatment Induces Neuroprotection in an In Vitro Model of Alzheimer’s Disease: A Transcriptomic Study

  2021cites this paper
• Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer’s Disease

  2021cites this paper
• Rapid changes of miRNAs-20, -30, −410, −515, −134, and −183 and telomerase with psychological activity: A one year study on the relaxation response and epistemological considerations

  2021cites this paper
• Association between structural brain features and gene expression by weighted gene co-expression network analysis in conversion from MCI to AD.

  2021cites this paper
• Long-term chronic caloric restriction alters miRNA profiles in the brain of ageing mice

  2021cites this paper
• G-quadruplexes originating from evolutionary conserved L1 elements interfere with neuronal gene expression in Alzheimer’s disease

  2021cites this paper
• Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging

  2021cites this paper
• A Signature of Five Long Non-Coding RNAs for Predicting the Prognosis of Alzheimer's Disease Based on Competing Endogenous RNA Networks

  2021cites this paper
• Mitochondrial dysfunction, mitophagy, and role of dynamin‐related protein 1 in Alzheimer's disease

  2021cites this paper
• MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases

  2020cites this paper
• The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease

  2020cites this paper
• Aβ-accelerated neurodegeneration caused by Alzheimer’s-associated ACE variant R1279Q is rescued by angiotensin system inhibition in mice

  2020cites this paper
• MicroRNAs in Hematopoietic Stem Cell Aging.

  2020cites this paper
• MicroRNAs alteration as early biomarkers for cancer and neurodegenerative diseases: New challenges in pesticides exposure

  2020cites this paper
• Epigenetics and Ageing

  2020cites this paper
• Dexmedetomidine attenuates cisplatin-induced cognitive impairment by modulating miR-429-3p expression in rats

  2020cites this paper
• Non-Coding RNAs Based Molecular Links in Type 2 Diabetes, Ischemic Stroke, and Vascular Dementia

  2020cites this paper
• Clinical Genetics and Genomics of Aging

  2020cites this paper
• miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease

  2020cites this paper
• Intervertebral disc regeneration: From cell therapy to the development of novel bioinspired endogenous repair strategies.

  2019cites this paper
• Small molecules as therapeutic drugs for Alzheimer's disease

  2019influential citation
• miRNAs as Biological Markers in the Diagnosis and Treatment of Alzheimer’s Disease

  2019influential citation
• MiR-409-5p as a Regulator of Neurite Growth Is Down Regulated in APP/PS1 Murine Model of Alzheimer’s Disease

  2019cites this paper
• MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?

  2019cites this paper
• Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.

  2019cites this paper
• Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease

  2019cites this paper
• Molecular Basis of Alzheimer’s Disease: Focus on Mitochondria

  2019cites this paper
• Relationship between single nucleotide polymorphisms in the 3′UTR of amyloid precursor protein and risk of Alzheimer’s disease and its mechanism

  2019cites this paper
• The emerging role of microRNA-4487/6845-3p in Alzheimer’s disease pathologies is induced by Aβ25–35 triggered in SH-SY5Y cell

  2018cites this paper
• Sulforaphane Inhibits Lipopolysaccharide-Induced Inflammation, Cytotoxicity, Oxidative Stress, and miR-155 Expression and Switches to Mox Phenotype through Activating Extracellular Signal-Regulated Kinase 1/2–Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Response Element Pathway in Murine

  2018cites this paper
• Effect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases

  2018cites this paper
• The RNA world of human ageing

  2018cites this paper
• Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases

  2017cites this paper
• Anti-inflammatory activity of resveratrol prevents inflammation by inhibiting NF‑κB in animal models of acute pharyngitis.

  2017cites this paper
• Some News on Old Concepts and the Epigenetics of Alzheimerâs Disease

  2017cites this paper
• Identification of the Role of miR-142-5p in Alzheimer’s Disease by Comparative Bioinformatics and Cellular Analysis

  2017cites this paper
• tigated the anti‐inflammatory effects of resveratrol in animal models of acute pharyngitis, and its possible mechanisms. Commercial ELISA kits were used to measure tumor necrosis factor-α, interleukin (IL)‐6, macrophage inflammatory protein‐2, cyclooxygenase‐2 levels and caspase‐3/9 activity. Toll‐l

  2017cites this paper
• Extracellular microRNAs as messengers in the central and peripheral nervous system

  2017cites this paper